Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders

Ophthalmology Clinics of North America

Volumn 18, Issue 4, 2005, Pages 511-528

  Hemady, Ramzi K ^a   Chan, Audrey S ^a   Nguyen, Anh T Q ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALLOPURINOL; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIMETABOLITE; AZATHIOPRINE; BROMOCRIPTINE; CHLORAMBUCIL; CIMETIDINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DICLOFENAC; ETANERCEPT; FLURBIPROFEN; FOLINIC ACID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; KETOCONAZOLE; KETOROLAC; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE; TACROLIMUS; UNINDEXED DRUG;

ALOPECIA; ANAPHYLAXIS; ANOREXIA; ARTHRALGIA; ARTHRITIS; BEHCET DISEASE; BLADDER CARCINOMA; BLADDER DISEASE; BLEEDING; BLEPHARITIS; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; BURNING SENSATION; CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; CONJUNCTIVAL HYPEREMIA; CORNEA DISEASE; CORNEA RODENT ULCER; DISEASE COURSE; DISEASE EXACERBATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRY EYE; DYSPNEA; ERYTHEMA; EYE DISEASE; EYE IRRITATION; FLU LIKE SYNDROME; FOLLICULITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GONAD DYSFUNCTION; GRAFT REJECTION; GRANULOMATOSIS; HEADACHE; HEART FAILURE; HEMORRHAGIC CYSTITIS; HIRSUTISM; HISTOPLASMOSIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPHEMA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATORY DISEASE; INJECTION SITE REACTION; INTERMEDIATE UVEITIS; INTERSTITIAL PNEUMONIA; INTRAOCULAR HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; LEUKEMIA; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; LUNG FIBROSIS; MULTIPLE SCLEROSIS; MYALGIA; MYCOSIS; NAUSEA; NEPHROTOXICITY; OPHTHALMOPLEGIA; OPPORTUNISTIC INFECTION; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; REVIEW; SCLERITIS; SEPSIS; SIDE EFFECT; SKIN CANCER; SKIN DISEASE; STOMATITIS; SUPERINFECTION; TERATOGENICITY; TREMOR; TUBERCULOSIS; URINARY TRACT INFECTION; UVEITIS; VISUAL IMPAIRMENT; VOMITING; WEGENER GRANULOMATOSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME; UVEITIS;

EID: 28444487184     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2005.07.002     Document Type: Review

References (102)

1. R.R. Tamesis, A. Rodriguez, and W.G. Christen Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease Ophthalmology 103 5 1996 768 775
2. L. Lane, R.R. Tamesis, and A. Rodriguez Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease Ophthalmology 102 10 1995 1530 1535
3. C.S. Foster, and A.T. Vitale Immunosuppressive chemotherapy C.S. Foster A.T. Vitale Diagnosis and treatment of uveitis 2002 WB Saunders Philadelphia 177 214 [Chapter 12]
4. R. Hemady, J. Tauber, and C.S. Foster Immunosuppressive drugs in immune and inflammatory ocular disease Surv Ophthalmol 35 5 1991 369 385
5. D.A. Jabs, J.T. Rosenbaum, and C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 4 2000 492 513
6. J. Puchta, L.O. Hattenbach, and H. Baatz Intraocular levels of methotrexate after oral low-dose treatment in chronic uveitis Ophthalmologica 219 1 2005 54 55
7. V.G. Wong Methotrexate treatment of uveal disease Am J Med Sci 251 2 1966 239 241
8. V.G. Wong Immunosuppressive agents in ophthalmology Surv Ophthalmol 13 1969 290 297
9. S. Dev, R.M. McCallum, and G.J. Jaffe Methotrexate treatment for sarcoid-associated pan uveitis Ophthalmology 106 1 1999 111 118
10. S.S. Shah, C.Y. Lowder, and M.A. Schmitt Low-dose methotrexate therapy for ocular inflammatory disease Ophthalmology 99 9 1992 1419 1423
11. I. Foeldvari, and A. Wierk Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis J Rheumatol 32 2 2005 362 365
12. P. McCluskey, J.H. Chang, and R. Singh Methotrexate therapy for ocular cicatricial pemphigoid Ophthalmology 111 4 2004 796 801
13. J.R. Smith, and J.T. Rosenbaum A role for methotrexate in the management of non-infectious orbital inflammatory disease Br J Ophthalmol 85 10 2001 1220 1224
14. S. Pascalis, G. Pia, and G. Aresu Combined cyclosporine A-steroid-methotrexate in endogenous non-infectious uveitis J Autoimmun 6 4 1993 467 480
15. A. Ravelli, C. Moretti, and F. Temporini Combination therapy with methotrexate and cyclosporin A in juvenile idiopathic uveitis Clin Exp Rheumatol 20 4 2002 567 572
16. L.D. Graham, B.L. Myones, and R.F. Rivas-Chacon Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis J Pediatr 120 3 1992 468 473
17. U. Wollina, K. Stander, and U. Barta Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis short and long term toxicity in 104 patients Clin Rheumatol 20 6 2001 406 410
18. C. Balachandran, P.J. McCluskey, and G.D. Champion Methotrexate-induced optic neuropathy Clin Experiment Ophthalmol 30 6 2002 440 441
19. H. Yazici, H. Pazarli, and C.G. Barnes A controlled trial of azathioprine in Behçet's disease N Engl J Med 322 5 1990 281 285
20. P.L. Hooper, and H.J. Kaplan Triple agent immunosuppression in serpiginous choroiditis Ophthalmology 98 6 1991 944 951
21. E.K. Akpek, S. Baltatzis, and J. Yang Long-term immunosuppressive treatment of serpiginous choroiditis Ocul Immunol Inflamm 9 3 2001 153 167
22. H.M. Leibowitz, and J.H. Elliott Chemotherapeutic immuno-suppression of the corneal graft rejection, I. Systemic antimetabolites Arch Ophthalmol 75 6 1966 826 835
23. F.M. Polack Effect of azathioprine (Imuran) on corneal graft rejection Am J Ophthalmol 64 2 1967 233 244
24. J. Barraquer Immunosuppressive agents in penetrating keratoplasty Am J Ophthalmol 100 1 1985 61 64
25. B.J. Mondino, and S.I. Brown Immunosuppressive therapy in ocular cicatricial pemphigoid Am J Ophthalmol 96 4 1983 453 459
26. J. Tauber, M. Sainz de la Maza, and C.S. Foster Systemic chemotherapy for ocular cicatricial pemphigoid Cornea 10 3 1991 185 195
27. Y. Yashima, and T. Ohgane Pharmacological profiles of mycophenolate mofetil (Cellcept), a new immunosuppressive agent Nippon Yakurigaku Zasshi 117 2 2001 131 137
28. G. Larkin, and S. Lightman Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease Ophthalmology 106 2 1999 370 374
29. J. Zurdel, B. Aboalchamat, and M. Zierhut Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid Klin Monatsbl Augenheilkd 218 4 2001 222 228
30. K. Greiner, M. Varikkara, and C. Santiago Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis Ophthalmologe 99 9 2002 691 694
31. S. Baltatzis, F. Tufail, and E.N. Yu Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders Ophthalmology 110 5 2002 1061 1065
32. C.H. Lau, M. Comer, and S. Lightman Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation Clin Experiment Ophthalmol 31 6 2003 487 491
33. H.N. Sen, E.B. Suhler, and S.Q. Al-Khatib Mycophenolate mofetil for the treatment of scleritis Ophthalmology 110 9 2003 1750 1755
34. A. Reis, T. Reinhard, and A. Voiculescu Mycophenolate mofetil versus cyclosporine A in high risk keratoplasty patients: a prospectively randomized clinical trial Br J Ophthalmol 83 11 1999 1268 1271
35. A.G. Mamo, and S.A. Azzam Treatment of Behçet's disease with chlorambucil Arch Ophthalmol 84 1970 446 450
36. B.A. Mudun, A. Ergen, and S.U. Ipcioglu Short-term chlorambucil for refractory uveitis in Behçet's disease Ocul Immunol Inflamm 9 4 2001 219 229
37. E. Miserocchi, S. Baltatzis, and A. Ekong Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience Ophthalmology 109 1 2002 137 142
38. D.A. Goldsten, F.A. Fontanilla, and S. Kaul Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation Ophthalmology 109 2 2002 370 377
39. C.S. Foster, S.L. Forstot, and L.A. Wilson Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis, effects of systemic immunosuppression Ophthalmology 91 10 1984 1253 1263
40. Y.A. Akova, N.S. Jabbur, and C.S. Foster Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy Ophthalmology 100 12 1993 1775 1781
41. C.S. Foster Systemic immunosuppressive therapy for progressive bilateral Mooren's ulcer Ophthalmology 92 10 1985 1436 1439
42. C.S. Foster, S.A. Wilson, and M.B. Ekins Immunosuppressive therapy for progressive ocular cicatricial pemphigoid Ophthalmology 89 4 1982 340 353
43. K. Durrani, G.N. Papaliodis, and C.S. Foster Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short term safety Ophthalmology 111 5 2004 960 965
44. T.J. Stillwell, and R.C. Benson Jr Cyclophosphamide induced hemorrhagic cystitis. A review of 100 patients Cancer 61 3 1988 451 457
45. Y. Samara, M. Hertz, and A. Lindner Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature Med Pediatr Onc 13 2 1985 86 91
46. C. Taller-Williams, Y.M. Hawaii, and M.M. Walther Cyclophosphamide- induced cystitis and bladder cancer in patients with Wegener's granulomatosis Ann Intern Med 124 5 1996 477 484
47. R.B. Nussenblatt, A.G. Palestine, and A.H. Rook Treatment of intraocular inflammatory disease with cyclosporine A Lancet 2 8344 1983 235 238
48. R.B. Nussenblatt, A.G. Palestine, and C.C. Chan Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents Am J Ophthalmol 96 3 1983 275 282
49. R.B. Nussenblatt, A.G. Palestine, and C.C. Chan Effectiveness of cyclosporine therapy for Behçet's disease Arthritis Rheum 28 6 1985 671 679
50. S. Lightman Use of steroids and immunosuppressive drugs in the management of posterior uveitis Eye 5 3 1991 294 298
51. A.T. Vitale, A. Rodriguez, and C.S. Foster Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis Ophthalmology 103 3 1996 365 373
52. D.J. Kilmartin, J.V. Forrester, and A.D. Dick Cyclosporin A therapy in refractory non-infectious childhood uveitis Br J Ophthalmol 82 7 1998 737 742
53. A.T. Vitale, A. Rodriguez, and C.S. Foster Low dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy Ophthalmology 101 5 1994 822 831
54. S. Rumelt, V. Bersudsky, and T. Blum-Hareuveni Systemic cyclosporine A in high failure risk, repeated corneal transplantation Br J Ophthalmol 86 9 2002 988 992
55. U. Pleyer Immunomodulation in penetrating keratoplasty. Current status and perspectives Ophthalmologe 100 12 2003 1036 1044
56. T. Reinhard, H. Spelsberg, and L. Henke Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency Ophthalmology 111 4 2004 775 782
57. E. Bertlmann, T. Reinhard, and U. Pleyer Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society Ophthalmologe 100 12 2003 1031 1035
58. M. Mochizuki, K. Masuda, and T. Sakane A clinical trial of FK506 in refractory uveitis Am J Ophthalmol 115 6 1993 763 769
59. M. Ishioka, S. Ohno, and S. Nakamura FK506 treatment of noninfectious uveitis Am J Ophthalmol 118 6 1994 723 729
60. T. Sakane, M. Mochizuki, and G. Inaba A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions Ryumachi 35 5 1995 802 813
61. C.M. Sloper, R.J. Powell, and H.S. Dua Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine Ophthalmology 106 4 1999 723 728
62. A. Reis, T. Reinhard, and R. Sundmacher A comparative investigation of FK506 and cyclosporine A in murine corneal transplantation Graefes Arch Clin Exp Ophthalmol 236 10 1998 785 789
63. C.M. Sloper, R.J. Powell, and H.S. Dua Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts Ophthalmology 108 10 2001 1838 1844
64. M.M. Lai, J.B. Kerrison, and N.R. Miller Reversible bilateral internuclear ophthalmoplegia associated with FK506 J Neurol Neurosurg Psychiatry 75 5 2004 776 778
65. J. Braun, and J. Spier Biological therapies in the spondyloarthropathies- the current state Rheumatol 43 9 2004 1072 1084
66. J.A. Smith, D.J. Thompson, and S.M. Whitcup A randomized placebo controlled double masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis Arthritis Rheum 53 1 2005 18 23
67. P.C. Falappone, F. Iannone, and C. Scioscia The treatment of recurrent uveitis with TNF-a inhibitors Reumatismo 56 3 2004 185 189
68. A. Reiff, S. Takei, and S. Sadeghi Etanercept therapy in children with treatment-resistant uveitis Arthritis Rheum 44 6 2001 1411 1415
69. C.S. Foster, F. Tufail, and N.K. Waheed Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate Arch Ophthalmol 121 4 2003 437 440
70. T. Tauber, D. Danile, and J. Barash Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis Rheumatol 44 3 2005 405
71. B. Haraoui Differentiating the efficacy of tumor necrosis factor inhibitors J Rheumatology 32(Suppl):74 2005 3 7
72. Y. El-Shabrawi, and J. Hermann Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis Ophthalmology 109 12 2002 2342 2346
73. A. Joseph, D. Raj, and H. Dua Infliximab in the treatment of refractory posterior uveitis Ophthalmology 110 7 2003 1449 1453
74. P.P. Sfikakis, P.G. Theodossiadis, and C.G. Katsiari Effect of infliximab on sight threatening panuveitis in Behçet's disease Lancet 358 9278 2001 295 296
75. R.B. Nussenblatt, D.J. Thompson, and Z. Li Humanized ant-interleukin-2 (IL-2) receptor alpha therapy: long term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration J Autoimmun 21 3 2003 283 293
76. R.B. Nussenblatt, J.S. Peterson, and C.S. Foster Initial evaluation of subcutaneous Daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series Ophthalmology 112 5 2005 764 770
77. G.N. Papaliodis, D. Chu, and C.S. Foster Treatment of ocular inflammatory disorders with Daclizumab Ophthalmology 110 4 2003 786 789
78. D. Stevenson, J. Tauber, and B. Reis Efficacy of cyclosporine A ophthalmic emulsion in the treatment of moderate to severe dry eye disease Ophthalmology 107 5 2000 967 974
79. E. Moss, R. Klein, and B. Klein Incidence of dry eye in an older population Arch Ophthalmol 122 2004 369 373
80. K. Sall, O.D. Stevenson, and T.K. Mundrof Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 4 2000 631 639
81. E.K. Akpek, J.K. Dart, and S. Watson A randomized trial of topical cyclosporin 0.05% in topical steroid resistant atopic keratoconjunctivitis Ophthalmology 111 3 2004 476 482
82. I. Bekersky, W. Fitzsimmons, and A. Tanase Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis J Am Acad Dermatol 44 1 Suppl 2001 S17 S27
83. J. Hanifin, M.R. Liny, and R. Langley Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy J Am Acad Dermatol 44 1 Suppl 2001 S28 S38
84. A.K. Freeman, J. Serle, and P. VanVeldhuisen Tacrolimus ointment in the treatment of eyelid dermatitis Cutis 73 4 2004 267 271
85. R.A. Mills, D.B. Jones, and C.R. Winkler Topical FK-506 prevents experimental corneal allograft rejection Cornea 14 2 1995 157 160
86. K. Okada, H. Sakata, and A. Minamoto Effect of FK 506 administered topical versus intramuscularly on suppression of the corneal immune reaction in rats Ophthalmologica 210 3 1996 175 179
87. N. Hikita, J.S. Lopez, and C.C. Chan Use of topical FK506 in a corneal graft rejection model in Lewis rats Invest Ophthalmol Vis Sci 38 5 1997 901 909
88. T. Sengoku, S. Sakuma, and S. Satoh Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models Clin Exp Allergy 33 11 2003 1555 1560
89. M.A. Joseph, H.E. Kaufman, and M. Insler Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders Cornea 24 4 2005 417 420
90. L.D. Waterbury, and A.J. Flach Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation J Ocul Pharmacol Ther 20 4 2004 345 352
91. J.A. Anderson, C.C. Chen, and J.B. Vita Disposition of topical flurbiprofen in normal and aphakic rabbit eyes Arch Ophthalmol 100 4 1982 642 645
92. D.D. Tand-Liu, S.S. Lui, and R.J. Weinkam Ocular and systemic bioavailability of ophthalmic flurbiprofen J Pharmacokinet Biopharm 12 6 1984 611 626
93. P.P. Ellis, D.S. Pfoff, and D.C. Bloedow Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application J Ocul Pharmacol 10 4 1994 677 682
94. A.J. Flach, R.C. Stegman, and J. Graham Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study Ophthalmology 97 10 1990 1253 1258
95. S. Sivaprasad, C. Bunce, and N. Patel Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery Cochrane Database Syst Rev 1 2005 Jan 25 CD004239
96. V.M. Weinstock, D.J. Weinstock, and S.J. Weinstock Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy J Refract Surg 12 7 1996 792 794
97. R. Goyal, J. Shankar, and D.L. Fone Randomized controlled trial of ketorolac in the management of corneal abrasion Acta Ophthalmol Scand 79 2 2001 177 179
98. M.B. Raizman Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine Clin Ther 17 5 1995 882 890
99. K.D. Solomon, J.W. Turkalj, and S.B. Whiteside Topical 0.5% ketorolac vs. 0.03% flurbiprofen for inhibition of miosis during cataract surgery Arch Ophthalmol 115 9 1997 1119 1122
100. A.C. Guidera, J.I. Luch, and I.J. Udell Keratitis ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs Ophthalmology 08 5 2001 936 944
101. N.G. Congdon, O.D. Schein, and P. von Kulajta Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs J Cataract Refract Surg 27 4 2001 622 631
102. V.E. Reviglio, T.S. Rana, and Q.J. Li Effects of topical nonsteroidal anti-inflammatory drugs on the expression of matrix metalloproteinases in the cornea J Cataract Refract Surg 29 5 2003 989 997